We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Biontech Se | LSE:0A3M | London | Ordinary Share | BIONTECH SE ADR |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 98.395 | 95.94 | 100.85 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1,373 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 03/2/2025 | 11:45 | UKREG | BioNTech Completes Acquisition of Biotheus |
| 03/2/2025 | 11:45 | UKREG | BioNTech schließt Übernahme von Biotheus ab |
| 14/1/2025 | 11:45 | UKREG | BioNTech gibt auf der 43. J.P. Morgan Healthcare-Konferenz Updates zur.. |
| 14/1/2025 | 11:45 | UKREG | BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan.. |
| 13/11/2024 | 11:45 | UKREG | BioNTech to Acquire Biotheus to Boost Oncology Strategy |
| 13/11/2024 | 11:45 | UKREG | BioNTech kündigt Übernahme von Biotheus zur beschleunigten Umsetzung der.. |
| 04/11/2024 | 11:45 | UKREG | BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2024 sowie.. |
| 04/11/2024 | 11:45 | UKREG | BioNTech Announces Third Quarter 2024 Financial Results and Corporate.. |
| 31/10/2024 | 11:45 | UKREG | BioNTech to Host Innovation Series R&D Day on November 14, 2024 |
| 31/10/2024 | 11:45 | UKREG | BioNTech veranstaltet am 14. November 2024 „Innovation Series Day“ zu.. |
1 Year Biontech Chart |
Intraday Biontech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
